@hopkinslabwcm.bsky.social
Out today in Cell Reports Medicine, work from our lab lead by the very talented Shalini Nath leverages data from the Kinome Atlas in our precision medicine pipeline to identify an ovarian cancer specific sensitivity to a RAS mimetic. (www.cell.com/cell-reports...
Unlocking the therapeutic potential of rigosertib as a selective therapy for ovarian cancer
Nath et al. use a precision oncology approach, integrating an assessment of kinome
activity with iterative drug screening, to show that rigosertib is an ovarian cancer-selective
agent and that combini...
www.cell.com
July 8, 2025 at 7:08 PM
Out today in Cell Reports Medicine, work from our lab lead by the very talented Shalini Nath leverages data from the Kinome Atlas in our precision medicine pipeline to identify an ovarian cancer specific sensitivity to a RAS mimetic. (www.cell.com/cell-reports...